|
|
|
|
LEADER |
04102nam a2200805Ia 4500 |
001 |
10.1016-j.ijbiomac.2021.02.070 |
008 |
220427s2021 CNT 000 0 und d |
020 |
|
|
|a 01418130 (ISSN)
|
245 |
1 |
0 |
|a COVID-19 as a worldwide selective event and bitter taste receptor polymorphisms: An ecological correlational study
|
260 |
|
0 |
|b Elsevier B.V.
|c 2021
|
856 |
|
|
|z View Fulltext in Publisher
|u https://doi.org/10.1016/j.ijbiomac.2021.02.070
|
520 |
3 |
|
|a Background: Given the observed olfactory and gustatory dysfunctions in patients with COVID-19 and recent findings on taste receptors possible important activities in the immune system, we elected to estimate the correlation between COVID-19 mortality and polymorphism of a particular type of bitter taste receptor gene called TAS2R38, in a worldwide epidemiological point of view. Methods: Pooled rate of each of the rs713598, rs1726866, rs10246939, and PAV/AVI polymorphisms of the TAS2R38 gene was obtained in different countries using a systematic review methodology and its relationship with the mortality of COVID-19. Data were analyzed by the comprehensive meta-analysis software and SPSS. Results: There was only a significant reverse Pearson correlation in death counts and PAV/AVI ratio, p = 0.047, r = −0.503. Also, a significant reverse correlation of PAV/AVI ratio and death rate was seen, r = −0.572 p = 0.021. rs10246939 ratio had a significant positive correlation with death rate, r = 0.851 p = 0.031. Further analysis was not significant. Our results showed that the higher presence of PAV allele than AVI, and a higher rate of G allele than A in rs10246939 polymorphism in a country, could be associated with lower COVID-19 mortality. While assessing all three polymorphisms showed a huge diversity worldwide. Conclusion: Due to extraoral activities of bitter taste receptor genes, especially in mucosal immunity, this gene seems to be a good candidate for future studies on COVID-19 pathophysiology. Also, the high worldwide diversity of TAS2R38 genes polymorphism and its possible assassination with mortality raises concerns about the efficiency of vaccine projects in different ethnicities. © 2021 Elsevier B.V.
|
650 |
0 |
4 |
|a allele
|
650 |
0 |
4 |
|a Alleles
|
650 |
0 |
4 |
|a Article
|
650 |
0 |
4 |
|a bitter taste
|
650 |
0 |
4 |
|a controlled study
|
650 |
0 |
4 |
|a coronavirus disease 2019
|
650 |
0 |
4 |
|a Correlation of Data
|
650 |
0 |
4 |
|a COVID-19
|
650 |
0 |
4 |
|a COVID-19
|
650 |
0 |
4 |
|a Databases, Factual
|
650 |
0 |
4 |
|a DNA polymorphism
|
650 |
0 |
4 |
|a ethnicity
|
650 |
0 |
4 |
|a factual database
|
650 |
0 |
4 |
|a G protein coupled receptor
|
650 |
0 |
4 |
|a gene frequency
|
650 |
0 |
4 |
|a gene function
|
650 |
0 |
4 |
|a genetic association
|
650 |
0 |
4 |
|a Genetic Association Studies
|
650 |
0 |
4 |
|a genetic association study
|
650 |
0 |
4 |
|a genetic predisposition
|
650 |
0 |
4 |
|a Genetic Predisposition to Disease
|
650 |
0 |
4 |
|a genetic variability
|
650 |
0 |
4 |
|a genetics
|
650 |
0 |
4 |
|a genotype
|
650 |
0 |
4 |
|a Genotype
|
650 |
0 |
4 |
|a human
|
650 |
0 |
4 |
|a Humans
|
650 |
0 |
4 |
|a meta analysis
|
650 |
0 |
4 |
|a mortality
|
650 |
0 |
4 |
|a Mortality
|
650 |
0 |
4 |
|a mortality rate
|
650 |
0 |
4 |
|a pathophysiology
|
650 |
0 |
4 |
|a Polymorphism
|
650 |
0 |
4 |
|a Polymorphism, Single Nucleotide
|
650 |
0 |
4 |
|a prevalence
|
650 |
0 |
4 |
|a Receptors, G-Protein-Coupled
|
650 |
0 |
4 |
|a single nucleotide polymorphism
|
650 |
0 |
4 |
|a T2R38 gene
|
650 |
0 |
4 |
|a TAS2R38 gene
|
650 |
0 |
4 |
|a taste
|
650 |
0 |
4 |
|a Taste
|
650 |
0 |
4 |
|a taste bud
|
650 |
0 |
4 |
|a taste receptors, type 2
|
650 |
0 |
4 |
|a vaccination
|
700 |
1 |
|
|a Abdi, M.H.
|e author
|
700 |
1 |
|
|a Ahmadi, S.R.
|e author
|
700 |
1 |
|
|a Ebrahimi, M.
|e author
|
700 |
1 |
|
|a Foroughian, M.
|e author
|
700 |
1 |
|
|a Hatami, N.
|e author
|
700 |
1 |
|
|a Javdani, F.
|e author
|
700 |
1 |
|
|a Kalani, N.
|e author
|
700 |
1 |
|
|a Keshavarz, P.
|e author
|
700 |
1 |
|
|a Mehramiz, N.J.
|e author
|
700 |
1 |
|
|a Mogharab, V.
|e author
|
700 |
1 |
|
|a Parsa, S.
|e author
|
700 |
1 |
|
|a Shahi, B.
|e author
|
700 |
1 |
|
|a Zarenezhad, M.
|e author
|
773 |
|
|
|t International Journal of Biological Macromolecules
|